Table 1

Characteristics of study population; N = 90 children
Characteristic (categorical variables) Summary Statistics, N (%)
Gender
  Male 53 (58.9)
  Female 37 (41.1)
Primary Caregiver
  Parent 59 (66.3)
  Other 30 (33.7)
Age at ART Initiation
  < 2 years 14 (15.6%)
  [2-5) years 25 (27.8%)
  ≥ 5 years 51 (56.7%)
ART Regimen
  3TC, ZDV, EFV 66 (73.3)
  3TC, ZDV, NVP 18 (20.0)
  Other 6 (6.7)
WHO HIV Clinical Stage
  I 6 (7.2)
  II 14 (16.9)
  III 32 (38.9)
  IV 31 (37.4)
Previous TB Diagnosis
  Negative 56 (62.2)
  Positive 34 (37.8)
Characteristics (continuous variables) Summary Statistics
Min, Max, Q1, Median Q3
Age at ART Initiation (months) 1.0 153.6 44.4 70.6 107.2
Number of Available Visits During Study Period 1 9 3 4 6
Time Between ART Initiation and First Available Visit (months) 0.0 8.5 0.4 1.4 3.0
Time Between ART Initiation and Last Available Visit (months) 0.0 32.0 10.0 16.0 21.0
CD4 Labs at First Available Visit Post ART Initiation
  Absolute Count (cells/μL) 9.0 3,293 339.0 663.0 1,075
  Log(Absolute Count) 2.2 8.1 5.8 6.5 7.0
  Percentile 0.0 50.5 10.3 16.9 26.6
Viral Load at First Available Visit Post ART Initiation
  Viral Load (Copies/mL) 63.0 3.6 × 106 400.0 463.0 10,600
  Log (Viral Load) 4.1 15.1 6.0 6.1 9.3

Abbreviations: ART Antiretroviral Therapy, 3TC Lamivudine, ZDV Zidovudine, NVP Nevirapine, EFV Efavirenz, WHO World Health Organization, TB Tuberculosis.

Barry et al.

Barry et al. BMC Infectious Diseases 2013 13:476   doi:10.1186/1471-2334-13-476

Open Data